» Articles » PMID: 31005044

Increased Protein and MRNA Expression of Corticotropin-releasing Factor (CRF), Decreased CRF Receptors and CRF Binding Protein in Specific Postmortem Brain Areas of Teenage Suicide Subjects

Overview
Date 2019 Apr 21
PMID 31005044
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Overactivity of hypothalamic-pituitary-adrenal (HPA) axis function has been implicated in depression and suicidal behavior. This is based on the observation of an abnormal dexamethasone (DEX) and DEX-adrenocorticotropic hormone (ACTH) test in patients with depression and suicidal behavior. Recently, some studies have also found abnormalities of glucocorticoid receptors (GR), mineralocorticoid receptors (MR), corticotropin releasing factor (CRF), CRF receptors (CRF-R) and CRF binding protein (CRF-BP) in depressed and suicidal patients. Some investigators have also observed increased levels of CRF in the cerebrospinal fluid (CSF) and altered levels of MR, GR and CRF in the postmortem brain of depressed and suicidal subjects. We have earlier reported decreased protein and mRNA expression of GR and GILZ, a chaperone protein, in the postmortem brain of teenage suicide subjects. We have further studied CRF and its receptors in different areas of the postmortem brain of suicide subjects, i.e., the prefrontal cortex (PFC), hippocampus (HIPPO), subiculum and amygdala (AMY) from teenage suicide subjects. The CRF and its receptors were determined in the PFC (Brodmann area 9), HIPPO, subiculum and different amygdaloid nuclei from 24 normal control subjects and 24 teenage suicide subjects. Protein expression of CRF, its receptors and CRF-BP was determined by immunolabeling using the Western blot technique and mRNA expression was determined by real-time PCR (qPCR) technique. We found that the mRNA levels of CRF were significantly increased in the PFC, in the central amygdaloid nucleus (CeAMY) and in the subiculum. mRNA levels of CRF-R1 and CRF-BP were significantly decreased in the PFC. We did not find any changes in the HIPPO of any of the CRF components we studied. When we compared the protein expression of CRF components we found that CRF was significantly increased and CRF-R1, CRF-R2 and CRF-BP significantly decreased in the PFC. On the other hand, there were no changes in the protein expression of CRF components in the HIPPO. Our results in the postmortem brain suggest that, as found by clinical studies in the CSF, there are significant alterations of CRF and its receptors in the postmortem brain of teenage suicide subjects. These alterations of CRF and its components were region-specific, as changes were not generally observed in the HIPPO.

Citing Articles

Recent advances in treatments for congenital adrenal hyperplasia.

Falhammar H, Lajic S, Nordenstrom A Nat Rev Endocrinol. 2025; .

PMID: 39934411 DOI: 10.1038/s41574-025-01089-w.


SKA2 enhances stress-related glucocorticoid receptor signaling through FKBP4-FKBP5 interactions in neurons.

Hartmann J, Klengel C, Dillmann L, Hisey E, Hafner K, Shukla R Proc Natl Acad Sci U S A. 2024; 121(52):e2417728121.

PMID: 39705315 PMC: 11670087. DOI: 10.1073/pnas.2417728121.


Network analysis of comorbid depression, suicidality and biomarkers on HPA axis among mood disorder patients to psychiatric emergency services.

Wang Y, You G, Han T, Liu Y, Li J, Ji X Transl Psychiatry. 2023; 13(1):203.

PMID: 37316541 PMC: 10267111. DOI: 10.1038/s41398-023-02503-5.


Alterations in pituitary adenylate cyclase-activating polypeptide in major depressive disorder, bipolar disorder, and comorbid depression in Alzheimer's disease in the human hypothalamus and prefrontal cortex.

Slabe Z, Balesar R, Verwer R, Van Heerikhuize J, Pechler G, Zorovic M Psychol Med. 2023; 53(16):7537-7549.

PMID: 37226771 PMC: 10755247. DOI: 10.1017/S0033291723001265.


Corticotropin releasing factor and drug seeking in substance use disorders: Preclinical evidence and translational limitations.

Mantsch J Addict Neurosci. 2022; 4.

PMID: 36531188 PMC: 9757758. DOI: 10.1016/j.addicn.2022.100038.


References
1.
Holsboer F . The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 2000; 23(5):477-501. DOI: 10.1016/S0893-133X(00)00159-7. View

2.
Holsboer F . Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J Affect Disord. 2001; 62(1-2):77-91. DOI: 10.1016/s0165-0327(00)00352-9. View

3.
Herman J, Mueller N . Role of the ventral subiculum in stress integration. Behav Brain Res. 2006; 174(2):215-24. DOI: 10.1016/j.bbr.2006.05.035. View

4.
Reul J, de Kloet E . Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology. 1985; 117(6):2505-11. DOI: 10.1210/endo-117-6-2505. View

5.
Behan D, Maciejewski D, Chalmers D, DE SOUZA E . Corticotropin releasing factor binding protein (CRF-BP) is expressed in neuronal and astrocytic cells. Brain Res. 1995; 698(1-2):259-64. DOI: 10.1016/0006-8993(95)01014-m. View